Home Search
geovax - search results
If you're not happy with the results, please do another search
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we follow, shows a spike in either...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
We're adding Citius Pharma to the Watch...
Major Mpox Outbreak in the Democratic Republic of Congo.
As Reported in NPR's Gates and Soda
Major Mpox Outbreak in the Democratic Republic of Congo is a Worry to Disease docs.
UPDATED APRIL 2, 2024
"It's...
Mpox Infections Rise to Almost Double Last Year’s Numbers.
The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of 2023.
The most recent...
Trump’s (DJT) up 48% Today
LIVE QUOTE
Our only thought is it would be a great idea, to give some of the stock to E Jean Carroll for her lawsuit...
Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...
Taking advantage of post reverse-split investor pessimism, is a VALID investing technique.
Altamira is developing and supplying peptide-based nanoparticle technologies for efficient RNA delivery to...
IMAC Holdings (BACK) Explodes 94% Higher Post Reverse Split, With 42 Million Shares Trading...
Simply Incredible! 2024 Will be the Year of Post Reverse Split Revenge!
Taking advantage of post reverse-split investor pessimism, is a VALID investing technique.
IMAC owns and...
China Remains at Risk to Future MonkeyPox Outbreaks.
GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox.
The World Health Organization just updated global...
Amylyx (AMLX) Go Kaboom!
The Above Chart Looks Nice..Goldman Sachs (see below) had $46 Price Target.
Market Capitalization at 9:20 $1.29 billion - with a 'B.'
Market Capitalization at 9:31...
U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.
New report nearly doubles the GeoVax addressable market of Immunocompromised Patients (i.e. potential customers) from 15 Million, to 23 Million patients! Not updated were...